Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenglin Ye

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 7, 2021
Distinct Patterns of Host Adherence by <i>Neisseria gonorrhoeae</i> Isolated from Experimental GonorrheaYingxia He, Song Zhang, Yingmiao Zhang, et al.
Viruses|May 27, 2023
β-Glucan Induces Training Immunity to Promote Antiviral Activity by Activating TBK1Guolei Wang, Zhiqiang Li, Mingfu Tian, et al.
The Lancet. Oncology|February 26, 2018
Adjuvant vemurafenib in resected, BRAF<sup>V600</sup> mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichele Maio, Karl Lewis, Lev Demidov, et al.
Frontiers in Cellular and Infection Microbiology|January 31, 2020
Murine SIGNR1 (CD209b) Contributes to the Clearance of Uropathogenic <i>Escherichia coli</i> During Urinary Tract InfectionsYingmiao Zhang, Song Zhang, Yingxia He, et al.
Contemporary Clinical Trials|December 31, 2017
Agreement in reporting between trial publications and current clinical trial registry in high impact journals: A methodological reviewSarah Daisy Kosa, Lawrence Mbuagbaw, Victoria Borg Debono, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2019
Health-related quality of life in patients with fully resected BRAF<sup>V600</sup> mutation-positive melanoma receiving adjuvant vemurafenibDirk Schadendorf, Anna Maria Di Giacomo, Lev Demidov, et al.
BMC Medical Research Methodology|July 17, 2013
A tutorial on sensitivity analyses in clinical trials: the what, why, when and howLehana Thabane, Lawrence Mbuagbaw, Shiyuan Zhang, et al.
Journal of Critical Care|March 18, 2014
Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter surveyDeborah Cook, Mark Duffett, Francois Lauzier, et al.
Cell Communication and Signaling : CCS|October 29, 2025
Senescent cells promote viral infection-associated inflammation and tissue damage through a robust NF-κB pathwayMingfu Tian, June Ma, Zhiqiang Li, et al.
Infectious Agents and Cancer|June 21, 2025
DC-SIGN (CD209)-mediated interactions between bacteria, lung cancer tissues, and macrophages promote cancer metastasisQiao Li, Nihal Hasan, Fei Zhao, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|June 7, 2021
Distinct Patterns of Host Adherence by <i>Neisseria gonorrhoeae</i> Isolated from Experimental GonorrheaYingxia He, Song Zhang, Yingmiao Zhang, et al.
Viruses|May 27, 2023
β-Glucan Induces Training Immunity to Promote Antiviral Activity by Activating TBK1Guolei Wang, Zhiqiang Li, Mingfu Tian, et al.
The Lancet. Oncology|February 26, 2018
Adjuvant vemurafenib in resected, BRAF<sup>V600</sup> mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichele Maio, Karl Lewis, Lev Demidov, et al.
Frontiers in Cellular and Infection Microbiology|January 31, 2020
Murine SIGNR1 (CD209b) Contributes to the Clearance of Uropathogenic <i>Escherichia coli</i> During Urinary Tract InfectionsYingmiao Zhang, Song Zhang, Yingxia He, et al.
Contemporary Clinical Trials|December 31, 2017
Agreement in reporting between trial publications and current clinical trial registry in high impact journals: A methodological reviewSarah Daisy Kosa, Lawrence Mbuagbaw, Victoria Borg Debono, et al.
European Journal of Cancer (Oxford, England : 1990)|November 10, 2019
Health-related quality of life in patients with fully resected BRAF<sup>V600</sup> mutation-positive melanoma receiving adjuvant vemurafenibDirk Schadendorf, Anna Maria Di Giacomo, Lev Demidov, et al.
BMC Medical Research Methodology|July 17, 2013
A tutorial on sensitivity analyses in clinical trials: the what, why, when and howLehana Thabane, Lawrence Mbuagbaw, Shiyuan Zhang, et al.
Journal of Critical Care|March 18, 2014
Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter surveyDeborah Cook, Mark Duffett, Francois Lauzier, et al.
Cell Communication and Signaling : CCS|October 29, 2025
Senescent cells promote viral infection-associated inflammation and tissue damage through a robust NF-κB pathwayMingfu Tian, June Ma, Zhiqiang Li, et al.
Infectious Agents and Cancer|June 21, 2025
DC-SIGN (CD209)-mediated interactions between bacteria, lung cancer tissues, and macrophages promote cancer metastasisQiao Li, Nihal Hasan, Fei Zhao, et al.
Pageof 7